| GSK’s blockbuster antidepressant Seroxat at centre of allegations Related items from OnMedica Most clinicians back moves to make pharma industry ties more transparent UK pays less than neighbours for cancer drugs MPs slam government for its poor management of Cancer Drugs Fund Cancer drug access in England is a ‘debacle’ The medicine price debate |
Monday, 15 February 2016
Pharma companies fined for anti-competitive tactics
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment